Jones Financial Companies
GLSI icon

Jones Financial Companies’s Greenwich LifeSciences GLSI Stock Holding History

Jones Financial Companies’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.3K Buy
3,400
+200
+6% +$4.87K ﹤0.01% 2997
2026
Q1 		$71.5K Buy
+3,200
New +$83.5K ﹤0.01% 2809
2025
Q3 		– Sell
-10
Closed -$90 – 4290
2025
Q2 		$90 Buy
+10
New +$95 ﹤0.01% 3954

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jones Financial Companies's GLSI Position: Q2 2026 in Review

Jones Financial Companies increased its Greenwich LifeSciences (GLSI) stake by 6.3% in Q2 2026, buying an estimated $4.87K and bringing the position to 3,400 shares worth $67.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

Jones Financial Companies first reported a position in GLSI in Q2 2025 and has held it in 3 quarters since. The position peaked at $71.5K in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Jones Financial Companies held 3,400 shares of Greenwich LifeSciences worth $67.3K as of Q2 2026.
  • Jones Financial Companies bought 200 Greenwich LifeSciences shares in Q2 2026, an estimated $4.87K.
  • Greenwich LifeSciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2997 holding.
  • Jones Financial Companies first reported a position in Greenwich LifeSciences in Q2 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Greenwich LifeSciences position peaked at $71.5K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.